Clinical Trials Logo

Ureteral Calculi clinical trials

View clinical trials related to Ureteral Calculi.

Filter by:

NCT ID: NCT04759417 Recruiting - Ureteric Stone Clinical Trials

Comparison of CHOKAI vs STONE Score to Predict the Presence of Ureteric Stones in Patients With Renal Colic: A Multi-center Prospective Observational Study

Start date: February 1, 2021
Phase:
Study type: Observational

Background: The STONE score has traditionally been used as a clinical prediction tool to predict the presence of ureteric stones in patients presenting with renal colic. More recently, the CHOKAI score was introduced and found to have superior diagnostic accuracy on both internal and external validation. Objective: Our study aims to externally validate and compare the use of both the CHOKAI and STONE score in a population of UAE patients presenting to the Emergency Department for renal colic. Methods: Over a period of approximately 6 months, the study will follow Emergency Department Physicians at each institution and retrieve data from their encounters with patients presenting with renal colic. Parameters for both CHOKAI and STONE scores will be logged, extracted and matched against a reference standard of CT scan to compare diagnostic accuracy of both scores to predict the presence of ureteric stones in this population. Goals: Evaluation of the findings will discern applicability of scores to the UAE population and contribute to reducing unnecessary radiation exposure. To our knowledge, no studies have compared the use of these scores to diagnose urolithiasis in the United Arab Emirates. Furthermore, this will be the first study to externally validate the CHOKAI score outside of Japan using a controlled, prospective design.

NCT ID: NCT04602403 Recruiting - Ureter Stone Clinical Trials

Does Tamsulosin Facilitate Semi-rigid Ureteroscopic

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

Ureteric calculi are one of the most common reasons for frequent Urolithiasis. The estimated prevalence is 8-13% of all calculi. Medical expulsive therapy (MET) is recommended by the European Association of Urology (EAU) (2013) for 5-10 mm ureteric stones to facilitate stone passage. For MET, alpha blockers, mainly tamsulosin, have shown efficacy in several randomized controlled trials. The underlying pathophysiology of this therapy is supported by the presence and distribution of adrenoreceptors in the ureter. Blocking the action of alpha-1 receptors by pharmacological agents (alpha blockers), such as alfuzosin, terazosin, doxazosin, and, most typically, tamsulosin, results in the relaxation of the ureteric smooth muscle. Ureteroscopy (URS) is the most commonly performed procedure for the treatment of ureteral calculi, with a high (>90%) stone-free rate after a single treatment. Advancing a rigid ureteroscope into a non-dilated ureter may be difficult and cause complications. Ureteric dilatation may provide access to stones, but not in all cases, and ureteral mucosal injury up to perforation might occur.

NCT ID: NCT04069013 Recruiting - Kidney Diseases Clinical Trials

Standard vs Mini-PCNL for the Treatment of Stone Disease

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Randomized comparison of patient outcomes following standard PCNL versus mini-PCNL.

NCT ID: NCT03730389 Recruiting - Ureteral Calculi Clinical Trials

External Physical Vibration Lithecbole(EPVL) Versus Traditional Treatment for 4-10 mm Ureteral Stone

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

The investigator aims to perform a prospective and randomized controlled trial evaluating the safety and efficacy of External Physical Vibration Lithecbole(EPVL) in treating 4-10 mm ureteral stone.

NCT ID: NCT03692715 Recruiting - Nephrolithiasis Clinical Trials

Antibiotic Prophylaxis Before Shock Wave Lithotripsy

APPEAL
Start date: September 27, 2018
Phase: Phase 4
Study type: Interventional

This is a two arm, double blind RCT comparing the use of a single dose ciprofloxacin prior to SWL to saline alone. The multicenter trial will be conducted with a pragmatic emphasis including both high volume and low volume sites internationally.

NCT ID: NCT02469766 Recruiting - Ureteric Stones Clinical Trials

Treatment of Upper Ureteric Stones

Start date: March 2015
Phase: Phase 4
Study type: Interventional

This study will be conducted to compare the success and complication rates of ureteroscopy, and shockwaves lithotripsy for treatment of upper ureteric stones ≤1 cm.

NCT ID: NCT02298465 Recruiting - Urinary Calculi Clinical Trials

ESWL for Distal Ureteric Stone: Supine Versus Prone

Start date: November 2014
Phase: N/A
Study type: Interventional

Extracorporeal shockwave lithotripsy (ESWL) for urinary stone is common and widespread nowadays. Approximately 80% of urinary stones are treated by ESWL. Traditionally distal ureteric stones are treated with ESWL in the prone position. However, as some patients cannot tolerate lying in the prone due to medical illness such as chronic obstructive pulmonary disease (COPD), some authors have reported using the supine approach of ESWL for treatment of distal ureter stones. No serious complications had developed in the patients who underwent supine approach. Only minor complications such as self-limiting blood in the urine, painful passage of urine, or local pain that had responded to oral painkillers. There were no serious complications encountered in children as well. In the most recent retrospective review by Tolley et al, they had revealed that patients who had underwent supine ESWL for distal ureteric stones had an improved stone-free rate compared with the traditional prone approach. Patient with radio-opaque distal ureteric stones (stones below the sacroiliac joint) on KUB X-ray, who have opted for ESWL treatment, are randomized into two groups: one undergoing ESWL in the supine position and the other undergoing ESWL in the prone position. Patients will be observed for two hours after ESWL before being discharged. Oral painkillers as necessary will be provided to the patient. The patients will have a KUB Xray at 2 weeks post-ESWL, and then monthly afterwards if required. If there are residual stones at the 2-week follow-up, the patient will be offered ESWL again. Patients are free to withdraw from the study at any time and will continue to be managed as per usual. The investigators aim to have 130 patients, with 65 patients in each group with an interim analyses to be performed when 66 patients have been recruited (33 patients in each group).

NCT ID: NCT02279927 Recruiting - Nephrolithiasis Clinical Trials

Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy

Start date: October 2014
Phase: N/A
Study type: Interventional

A prospective study comparing different laser settings used for stone fragmentation during ureteroscopy

NCT ID: NCT02139059 Recruiting - Acute Renal Failure Clinical Trials

Delayed or Direct Ureteroscopy in the Treatment of Pediatric Calcular Anuria

Start date: June 2014
Phase: N/A
Study type: Interventional

To compare staged ureteroscopy following initial urinary drainage versus direct ureteroscopy without initial urinary drainage in the treatment of obstructive calcular anuria with acute renal failure in children.

NCT ID: NCT01884870 Recruiting - Urinary Calculi Clinical Trials

Silent Ureteral Stone: Impact on Renal Function and Kidney Anatomy

Start date: November 2012
Phase: N/A
Study type: Interventional

Ureteral stones may be silent in 5.3% of patients. The goal of this study was to prospectively evaluate the impact of a silent ureteral stone on renal function.